Clinical trials

6

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Management Arm) in the treatment of subjects with symptomatic unilateral iliofemoral DVT. The study will collect data on demographics, comorbidities, details from the DVT diagnosis and treatment, and clinical outcomes through the 6-month follow up visit.

Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Inari MedicalUpdated: Jul 2, 2026Locations: 64
Eligibility criteria

Age ≥ 18 years [+4]

Bilateral iliofemoral DVT [+20]

Status: Recruiting

RevCore for In Stent Thrombosis

The purpose of this research is to collect information about how the RevCore Thrombectomy Catheter works to treat stent blockages.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Inari MedicalUpdated: Jun 15, 2026Locations: 16
Eligibility criteria

Age ≥ 18 years [+4]

Exposed stents with broken struts, significantly deformed struts, struts protrud... [+11]

Status: Recruiting

The PEERLESS II Study

This study is a prospective, multicenter, randomized controlled trial of the FlowTriever System plus anticoagulation compared to anticoagulation alone for intermediate-risk acute PE.

Participants needed: 1,200
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Inari MedicalUpdated: Jun 10, 2026Locations: 83
Eligibility criteria

Age at enrollment ≥ 18 years [+4]

Unable to be anticoagulated with heparin, enoxaparin or other parenteral antithr... [+16]

Status: Recruiting

Inari VISION Registry

This registry is a global prospective, non-randomized, multicenter, observational, active post-market data collection of Inari Medical devices and products.

Participants needed: 1,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Inari MedicalUpdated: Jun 4, 2026Locations: 10Duration: 180 Days
Eligibility criteria

Willing and able to provide informed consent per institution and geographical re... [+3]

Is or will be inaccessible for registry follow-up [+3]

Status: Recruiting

The PERSEVERE Study

Randomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Inari MedicalUpdated: Jun 4, 2026Locations: 26
Eligibility criteria

Age at enrollment ≥18 years [+4]

Prolonged cardiac arrest with loss of consciousness associated with neurological... [+15]

Status: Recruiting

The ArtixASCEND Study

This study is a post-market, prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the Artix Thrombectomy System in patients with acute lower extremity arterial occlusions.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Inari MedicalUpdated: Jun 2, 2026Locations: 14
Eligibility criteria

Age ≥ 18 years [+6]

Life expectancy < 6 months [+10]